Opinion: Chemokines: More than just road signs

Nature Reviews Immunology

Volumn 6, Issue 2, 2006, Pages 159-164

  Bachmann, Martin F ^a   Kopf, Manfred ^b   Marsland, Benjamin J ^b  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CC CHEMOKINE LIGAND 3; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CYCLOSPORIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CHEMOTAXIS; DENDRITIC CELL; HUMAN; INFLAMMATION; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION; ANIMAL; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; HUMANS;

EID: 33644848119     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1776     Document Type: Review

References (52)

1. Ansel, K. M., McHeyzer-Williams, L. J., Ngo, V. N., McHeyzer-Williams, M. G. & Cyster, J. G. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190, 1123-1134 (1999).
2. H2s. J. Exp. Med. 187, 129-134 (1998).
3. Sallusto, F. et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29, 2037-2045 (1999).
4. Sallusto, F. et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769 (1998).
5. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
6. Pulendran, B., Palucka, K. & Banchereau, J. Sensing pathogens and tuning immune responses. Science 293, 253-256 (2001).
7. Geijtenbeek, T. B., van Vliet, S. J., Engering, A., 't Hart, B. A. & van Kooyk, Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22, 33-54 (2004).
8. Inohara, N. & Nunez, G. NODs: intracellular proteins involved in inflammation and apoptosis. Nature Rev. Immunol. 3, 371-382 (2003).
9. Rogers, N. C. et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507-517 (2005).
10. Sozzani, S. et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161, 1083-1086 (1998).
11. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H. & Yamaguchi, Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is upregulated upon maturation. J. Immunol. 161, 3096-3102 (1998).
12. Dieu, M. C. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386 (1998).
13. Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33 (1999).
14. Gunn, M. D. et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl Acad. Sci. USA 95, 258-263 (1998).
15. Yoshida, R. et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 272, 13803-13809 (1997).
16. Gunn, M. D. et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189, 451-460 (1999).
17. Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G. & Cyster, J. G. Co-expression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl Acad. Sci. USA 97, 12694-12699 (2000).
18. Marsland, B. J. et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22, 493-505 (2005).
19. Junt, T. et al. Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J. Immunol. 168, 6032-6040 (2002).
20. Ueno, T. et al. CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J. Exp. Med. 200, 493-505 (2004).
21. Junt, T. et al. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. J. Immunol. 173, 6684-6693 (2004).
22. Yanagawa, Y. & Onoe, K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant upregulation of Cdc42 and Rac activities. Blood 101, 4923-4929 (2003).
23. Yanagawa, Y. & Onoe, K. CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100, 1948-1956 (2002).
24. Sanchez-Sanchez, N. et al. Chemokine receptor CCR7 induces intracellular signalling that inhibits apoptosis of mature dendritic cells. Blood 104, 619-625 (2004).
25. Lee, Y., Eo, S. K., Rouse, R. J. & Rouse, B. T. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. Virology 312, 169-180 (2003).
26. Hillinger, S. et al. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-γ-dependent antitumour responses in a lung cancer model. J. Immunol. 171, 6457-6465 (2003).
27. - dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation. Virology 327, 8-15 (2004).
28. H2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411 (2000).
29. Braun, M. C., Lahey, E. & Kelsall, B. L. Selective suppression of IL-12 production by chemoattractants. J. Immunol. 164, 3009-3017 (2000).
30. -/- mice. J. Immunol. 165, 2603-2611 (2000).
31. Traynor, T. R., Kuziel, W. A., Toews, G. B. & Huffnagle, G. B. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164, 2021-2027 (2000).
32. Molon, B. et al. T cell co-stimulation by chemokine receptors. Nature Immunol. 6, 465-471 (2005).
33. Karpus, W. J. et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158, 4129-4136 (1997).
34. Haegel-Kronenberger, H. et al. Adhesive and/or signalling functions of CD44 isoforms in human dendritic cells. J. Immunol. 161, 3902-3911 (1998).
35. H1 responses. J. Immunol. 166, 1611-1617 (2001).
36. Brand, U. et al. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 28, 1673-1680 (1998).
37. Scandella, E. et al. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103, 1595-1601 (2004).
38. Partida-Sanchez, S. et al. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 20, 279-291 (2004).
39. + T cell populations lacking helper function. Nature Immunol. 6, 163-170 (2005).
40. + T cells mediate CD40-independent maturation of dendritic cells in vivo. J. Exp. Med. 189, 1875-1884 (1999).
41. Mintern, J. D., Davey, C. M., Belz, C. T., Carbone, F. R. & Heath, W. R. Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J. Immunol. 168, 977-980 (2002).
42. Fujii, S., Liu, K., Smith, C., Bonito, A. J. & Steinman, R. M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 co-stimulation. J. Exp. Med. 199, 1607-1618 (2004).
43. Alexander, J. & Hunter, C. A. Immunoregulation during toxoplasmosis. Chem. Immunol. 70, 81-102 (1998).
44. + dendritic cells. Nature Immunol. 1, 83-87 (2000).
45. Aliberti, J. et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nature Immunol. 4, 485-490 (2003).
46. Billich, A., Winkler, G., Aschauer, H., Rot, A. & Peichl, P. Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J. Exp. Med. 185, 975-980 (1997).
47. Sherry, B., Yarlett, N., Strupp, A. & Cerami, A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc. Natl Acad. Sci. USA 89, 3511-3515 (1992).
48. Xu, Q., Leiva, M. C., Fischkoff, S. A., Handschumacher, R. E. & Lyttle, C. R. Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267, 11968-11971 (1992).
49. Lin, C. L. et al. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192, 587-594 (2000).
50. + T cells. J. Immunol. 155, 4111-4117 (1995).
51. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P. & Steinman, R. M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl Acad. Sci. USA 101, 7669-7674 (2004).
52. Majumder, B. et al. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J. Virol. 79, 7990-8003 (2005).